Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Rilpivirine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,052Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Laurus’s Generics Emtricitabine Receives Approval in US
    Laurus’s Generics Emtricitabine Receives Approval in US

    04 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220232

    FDA
    04 Mar 2026
    Share Share
    GSK Props Up Its Cabenuva In Adolescents With Long-Term Data
    GSK Props Up Its Cabenuva In Adolescents With Long-Term Data

    26 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/gsks-viiv-confirms-staying-power-long-acting-hiv-treatment-cabenuva-adolescents

    FIERCE PHARMA
    26 Feb 2026
    Share Share
    ViiV Health: Long-Acting Cabenuva Maintains HIV Control in Teens
    ViiV Health: Long-Acting Cabenuva Maintains HIV Control in Teens

    26 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-26/viiv-healthcare-reports-long-acting-injectable-cabenuva-effectively-maintains-viral-suppression-in-adolescents-living-with-hiv-with-97-preferring

    PHARMIWEB
    26 Feb 2026
    Share Share
    Viiv Pharma Unveils Long-Acting HIV Breakthroughs At CROI 2026
    Viiv Pharma Unveils Long-Acting HIV Breakthroughs At CROI 2026

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217311861/en/ViiV-Healthcare-showcases-long-acting-HIV-innovation-and-potential-of-ultra-long-acting-pipeline-including-new-data-for-first-third-generation-integrase-inhibitor-at-CROI-2026

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    Somerset’s Generics Rilpivirine Receives Tentative Approval in US
    Somerset’s Generics Rilpivirine Receives Tentative Approval in US

    20 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218798

    FDA
    20 Aug 2025
    Share Share
    Viatris’ Emtricitabine Rilpivirine Receives Approval In Europe
    Viatris’ Emtricitabine Rilpivirine Receives Approval In Europe

    19 Aug 2025

    // EMA

    https://www.ema.europa.eu/en/documents/overview/emtricitabine-rilpivirine-tenofovir-alafenamide-viatris-epar-medicine-overview_en.pdf

    EMA
    19 Aug 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.